Skip to main content

Test Updates


Clinical Labs of Hawaii provides test updates for educational purposes to physicians, specialists, and the general public.


Test Update Date

QuantiFERON® TB Gold Plus Assay Test Update

Effective October 30, 2023, Clinical Labs of Hawaii (CLH) will move Quantiferon testing from the Thunderbolt® (ELISA) to the Diasorin Liaison XL® (CLIA) analyzer.


H. Pylori Breath Test - Manufacturer Change

Effective August 28, 2023, Clinical Labs of Hawaii (CLH) will transition to the Gulf Coast Scientific™ PyloPlus® Urea Breath Test (UBT) for detection of Helicobacter pylori.


HPV Testing - Updated Cytology Test Options

Effective July 1, 2023, CLH/PPP will be updating our Cytology GYN test options and will include HPV (Patient-Self-Collected) specimens as an acceptable source.


Specimen Labeling and Requisition Requirements

Clinical Labs of Hawaii (CLH) and Pan Pacific Pathologists (PPP) are required by The Joint Commission (TJC) and the College of American Pathologists (CAP) to only accept specimens meeting labelling and requisition requirements.


HMSA Avalon Genetic Testing

Effective June 1, 2023 HMSA will be implementing their Avalon Genetic Testing Management (GTM) Program to streamline the management of genetic testing services.


Rubella Antibody Screening

Effective April 24, 2023, CLH will replace Rubella Antibody Total with the Rubella IgG Antibody Test.


Vaginitis Testing

Effective April 24, 2023, CLH will offer the Hologic Aptima ® Vaginitis Panel.


Mycoplasma genitalium Assay

Effective April 24, 2023, CLH will offer the Hologic Aptima ® Mycoplasma genitalium NAAT Assay.



Effective 08/02/22, Clinical Labs will be offering Monkeypox testing.


Respiratory Panel, PCR and Gastrointestinal (GI) Panel, PCR Update

Effective immediately, the Respiratory Panel, PCR (PLA 0202U) and Gastrointestinal (GI) Panel, PCR (PLA 0097U) will no longer be offered as outpatient tests.


Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program

Effective March 22, 2022, the HRSA program will no longer accept claims for COVID-19 testing and treatment for uninsured patients.


Rapid Influenza by NAAT Test Update

Effective February 1, 2022, Clinical Labs of Hawaii will be transitioning to a new molecular platform for Influenza A and B testing.


Change in COVID-19 Alert Protocol

Effective January 7th, 2022, Clinical Labs of Hawaii (CLH) will be updating COVID-19 alert protocol. Due to the significant increase in COVID-19 positives and the improved ability for healthcare providers and patients to receive results in real-time via electronic methods, CLH will discontinue automatically calling COVID-19 positives to the ordering provider.


eGFR Calculation (Removal of Race-Based Adjustment) Test Update

In response to recommendations from the National Kidney Foundation and American Society of Nephrology (NKF- ASN) Task Force on estimated glomerular filtration rate (eGFR), effective December 12, 2021, Clinical Labs of Hawaii will adopt the single refitted CKD-EPI equation for all serum creatinine measures.


Strep Group A by NAAT

Effective October 25, 2021, Clinical Labs of Hawaii will be transitioning to the Abbott ID NOW ™ molecular platform for the detection of nucleic acid from Streptococcus pyogenes (Group A Streptococcus).